Hydroxychloroquine for early treatment of adults with mild coronavirus disease 2019: a randomized, controlled trial

O Mitjà, M Corbacho-Monné, M Ubals… - Clinical Infectious …, 2021 - academic.oup.com
Background No effective treatments for coronavirus disease 2019 (COVID-19) exist. We
aimed to determine whether early treatment with hydroxychloroquine (HCQ) would be …

[HTML][HTML] Epidemiology and determinants of reemerging bacterial sexually transmitted infections (STIs) and emerging STIs in Europe

O Mitjà, V Padovese, C Folch, I Rossoni… - The Lancet Regional …, 2023 - thelancet.com
In this scoping review, we offer a comprehensive understanding of the current and recent
epidemiology, challenges, and emerging issues related to bacterial sexually transmitted …

Reemergence of the HIV epidemic among men who have sex with men in North America, Western Europe, and Australia, 1996–2005

PS Sullivan, O Hamouda, V Delpech, JE Geduld… - Annals of …, 2009 - Elsevier
PURPOSE: To describe and contextualize changes in rates of human immunodeficiency
virus (HIV) notifications in men who have sex with men (MSM) in eight countries (Australia …

[HTML][HTML] A cluster-randomized trial of hydroxychloroquine for prevention of Covid-19

O Mitjà, M Corbacho-Monné, M Ubals… - … England Journal of …, 2021 - Mass Medical Soc
Background Current strategies for preventing severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection are limited to nonpharmacologic interventions …

Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain

C Suñer, M Ubals, EJ Tarín-Vicente… - The Lancet Infectious …, 2023 - thelancet.com
Background Monkeypox DNA has been detected in skin lesions, saliva, oropharynx, urine,
semen, and stool of patients infected during the 2022 clade IIb outbreak; however, the viral …

[HTML][HTML] Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological …

A Mocroft, JD Lundgren, ML Sabin, AA Monforte… - PLoS …, 2013 - journals.plos.org
Background Few studies have monitored late presentation (LP) of HIV infection over the
European continent, including Eastern Europe. Study objectives were to explore the impact …

Long-term mortality in HIV-positive individuals virally suppressed for> 3 years with incomplete CD4 recovery

FN Engsig, R Zangerle, O Katsarou… - Clinical infectious …, 2014 - academic.oup.com
Background. Some human immunodeficiency virus (HIV)–infected individuals initiating
combination antiretroviral therapy (cART) with low CD4 counts achieve viral suppression but …

Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a …

DK Nomah, J Reyes-Urueña, Y Díaz, S Moreno… - The Lancet …, 2021 - thelancet.com
Background Factors affecting outcomes of SARS-CoV-2 infection in people living with HIV
are unclear. We assessed the factors associated with SARS-CoV-2 diagnosis and severe …

[HTML][HTML] HIV and SARS-CoV-2 co-infection: epidemiological, clinical features, and future implications for clinical care and public health for people living with HIV …

DK Nomah, J Reyes-Urueña, JM Llibre… - Current HIV/AIDS …, 2021 - Springer
Abstract Purpose of Review The purpose of this review is using the currently available
clinical and epidemiological data, to identify key aspects to improve both the clinical …

[HTML][HTML] The impact of the COVID-19 pandemic on Sexually Transmitted Infections surveillance data: incidence drop or artefact?

A Sentís, A Prats-Uribe, E López-Corbeto… - BMC public health, 2021 - Springer
Background Before the COVID-19 pandemic, Sexually transmitted infections (STIs) were
increasing in Europe, and Spain and Catalonia were not an exception. Catalonia has been …